Invicro, A Konica Minolta Company
Invicro welcomes you to the 2021 Virtual ASGCT Meeting!
Invicro's mission is to accelerate clinical drug development using state-of-the-art imaging and pathology technologies. Invicro’s multidisciplinary team provides solutions to biopharmaceutical companies across all stages of drug development, imaging modalities and therapeutic areas, including neurology, oncology, immuno-oncology, and rare diseases. Invicro’s quantitative biomarker services, advanced analytics and AI tools, and clinical operational services are backed by an industry-leading software informatics platforms, VivoQuant™ and iPACS®.
Brands: To learn more about how we support drug discovery and development, visit www.invicro.com